173 related articles for article (PubMed ID: 37558271)
1. Is neglect of self-clearance biasing TB vaccine impact estimates?
Scarponi D; Clark RA; Weerasuriya CK; Emery J; Houben RMGJ; White R; McCreesh N
BMJ Glob Health; 2023 Aug; 8(8):. PubMed ID: 37558271
[TBL] [Abstract][Full Text] [Related]
2. Is neglect of self-clearance biassing TB vaccine impact estimates?
Scarponi D; Clark RA; Weerasuriya C; Emery JC; Houben RM; White RG; McCreesh N
medRxiv; 2023 May; ():. PubMed ID: 37090535
[TBL] [Abstract][Full Text] [Related]
3. New tuberculosis vaccines in India: modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01
Clark RA; Weerasuriya CK; Portnoy A; Mukandavire C; Quaife M; Bakker R; Scarponi D; Harris RC; Rade K; Mattoo SK; Tumu D; Menzies NA; White RG
BMC Med; 2023 Aug; 21(1):288. PubMed ID: 37542319
[TBL] [Abstract][Full Text] [Related]
4. Potential impact of tuberculosis vaccines in China, South Africa, and India.
Harris RC; Sumner T; Knight GM; Zhang H; White RG
Sci Transl Med; 2020 Oct; 12(564):. PubMed ID: 33028708
[TBL] [Abstract][Full Text] [Related]
5. Self-clearance of
Emery JC; Richards AS; Dale KD; McQuaid CF; White RG; Denholm JT; Houben RMGJ
Proc Biol Sci; 2021 Jan; 288(1943):20201635. PubMed ID: 33467995
[No Abstract] [Full Text] [Related]
6. Age-targeted tuberculosis vaccination in China and implications for vaccine development: a modelling study.
Harris RC; Sumner T; Knight GM; Evans T; Cardenas V; Chen C; White RG
Lancet Glob Health; 2019 Feb; 7(2):e209-e218. PubMed ID: 30630775
[TBL] [Abstract][Full Text] [Related]
7. The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China.
Weerasuriya CK; Harris RC; McQuaid CF; Bozzani F; Ruan Y; Li R; Li T; Rade K; Rao R; Ginsberg AM; Gomez GB; White RG
BMC Med; 2021 Feb; 19(1):60. PubMed ID: 33632218
[TBL] [Abstract][Full Text] [Related]
8. Prospects for a vaccine to prevent HIV-related tuberculosis.
Nemes E; Scriba TJ; Hatherill M
Curr Opin HIV AIDS; 2018 Nov; 13(6):522-527. PubMed ID: 30080682
[TBL] [Abstract][Full Text] [Related]
9. New tuberculosis vaccines in India: Modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01
Clark RA; Weerasuriya CK; Portnoy A; Mukandavire C; Quaife M; Bakker R; Scarponi D; Harris RC; Rade K; Mattoo SK; Tumu D; Menzies NA; White RG
medRxiv; 2023 Jul; ():. PubMed ID: 36865172
[TBL] [Abstract][Full Text] [Related]
10. Model-based impact evaluation of new tuberculosis vaccines in aging populations under different modeling scenarios: the case of China.
Tovar M; Sanz J; Moreno Y
Front Public Health; 2024; 12():1302688. PubMed ID: 38463158
[TBL] [Abstract][Full Text] [Related]
11. The potential health and economic impacts of new tuberculosis vaccines under varying delivery strategies in Delhi and Gujarat, India: a modelling study.
Clark RA; Portnoy A; Weerasuriya CK; Sumner T; Bakker R; Harris RC; Rade K; Mattoo SK; Tumu D; Menzies NA; White RG
medRxiv; 2023 Sep; ():. PubMed ID: 37808744
[TBL] [Abstract][Full Text] [Related]
12. Potential impact of spatially targeted adult tuberculosis vaccine in Gujarat, India.
Shrestha S; Chatterjee S; Rao KD; Dowdy DW
J R Soc Interface; 2016 Mar; 13(116):. PubMed ID: 27009179
[TBL] [Abstract][Full Text] [Related]
13. The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study.
Clark RA; Mukandavire C; Portnoy A; Weerasuriya CK; Deol A; Scarponi D; Iskauskas A; Bakker R; Quaife M; Malhotra S; Gebreselassie N; Zignol M; Hutubessy RCW; Giersing B; Jit M; Harris RC; Menzies NA; White RG
Lancet Glob Health; 2023 Apr; 11(4):e546-e555. PubMed ID: 36925175
[TBL] [Abstract][Full Text] [Related]
14. Developing whole mycobacteria cell vaccines for tuberculosis: Workshop proceedings, Max Planck Institute for Infection Biology, Berlin, Germany, July 9, 2014.
Whole Mycobacteria Cell Vaccines for Tuberculosis Summary Group
Vaccine; 2015 Jun; 33(26):3047-55. PubMed ID: 25882170
[TBL] [Abstract][Full Text] [Related]
15. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
16. Tuberculosis: Current Status, Diagnosis, Treatment and Development of Novel Vaccines.
Yadav J; Verma S; Chaudhary D; Jaiwal PK; Jaiwal R
Curr Pharm Biotechnol; 2019; 20(6):446-458. PubMed ID: 31208308
[TBL] [Abstract][Full Text] [Related]
17. Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine.
Gupta N; Garg S; Vedi S; Kunimoto DY; Kumar R; Agrawal B
Front Immunol; 2018; 9():2371. PubMed ID: 30386336
[TBL] [Abstract][Full Text] [Related]
18. The dream of a vaccine against tuberculosis; new vaccines improving or replacing BCG?
MartÃn C
Eur Respir J; 2005 Jul; 26(1):162-7. PubMed ID: 15994403
[TBL] [Abstract][Full Text] [Related]
19. New tuberculosis vaccines: advances in clinical development and modelling.
Weerasuriya CK; Clark RA; White RG; Harris RC
J Intern Med; 2020 Dec; 288(6):661-681. PubMed ID: 33128834
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]